1 terminated. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Terminated 1 |
Follow Beth Faiman: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Glutamine in Preventing Peripheral Neuropathy in Patients With Multiple Myeloma Receiving Bortezomib glutamine, quality-of-life assessment, placebo - Chemotherapeutic Agent Toxicity, Multiple Myeloma | Phase 2 | Terminated | Beth Faiman | 9 | 2013-02-01 | 2019-10-22 |
Multiple Myeloma (1) · Peripheral Nervous System Diseases (1)
Glutamine (1)
United States (1)